City
Epaper

RDIF seeks Sputnik M vaccine registration for adolescents in India

By IANS | Updated: December 6, 2021 22:10 IST

New Delhi, Dec 6 The Russian Direct Investment Fund (RDIF) said on Monday that it has provided documents ...

Open in App

New Delhi, Dec 6 The Russian Direct Investment Fund (RDIF) said on Monday that it has provided documents to India's regulator for the registration of Sputnik M, the vaccine for adolescents aged 12-17.

"RDIF has provided India's regulator with documents for registration of Sputnik M - the vaccine for adolescents aged 12-17. Russia's Health Ministry registered Sputnik M on November 24. It has become a new member of the Sputnik vaccines family and is offered to international markets, joining Sputnik V and Sputnik Light," the RDIF said in a statement.

"Subject to the positive decision of India's authorities, Sputnik M could become the first registered vaccine for adolescents in the country and make an important contribution in protecting the younger population," the statement added.

The Sputnik V vaccine is already being used in India after it received emergency use authorisation in April 2021. Sputnik V is the first foreign-made vaccine to be used in India.

The RDIF is also working with India's regulatory authorities for the registration of Sputnik Light, the one shot vaccine based on human adenovirus serotype 26, as a standalone vaccine and a universal booster.

Partnering Dr. Reddy's Laboratories, RDIF has conducted additional clinical trials of Sputnik Light in India. The data from these trials have been presented to the Drugs Controller General of India (DCGI).

Kirill Dmitriev, the CEO of RDIF, said, "Russia and India joined forces since the beginning of the pandemic. A number of agreements with partners in India have helped RDIF significantly increase its production capabilities. We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives."

The RDIF has expressed hope that Sputnik Light could be successfully applied as a booster dose in partnership with the Serum Institute of India, which already produces the two vaccines.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Russian Direct Investment FundindiaNew DelhiHealth MinistryThe new delhi municipal councilDelhi south-westIndiUk-indiaKirill dmitrievRepublic of indiaIndia india
Open in App

Related Stories

NationalOperation Sindhu: “We Saw Drones, Missiles,” Say Evacuated Students Recounting Life in Iran’s Warzone

NationalCOVID-19 Update: Mumbai Cases Drop Sharply; India’s Active Tally Drops By 428

CricketIndia vs India A Intra-Squad LIVE Streaming: When and Where To Watch Intra-Squad Match on TV and Online?

Navi MumbaiNavi Mumbai News: Border Crackdown Forces Indian Woman to Part With Children and Husband Amid Citizenship Chaos

NationalAir India Plane Crash in Gujarat: Could This Be One of India’s Deadliest Air Disasters? Here Are Top 5 Worst Aviation Tragedies

Health Realted Stories

HealthHundreds across Pacific nations participate in International Day of Yoga

HealthUSFDA okays Lenacapavir: Affordable, generic India-made drug key to boost global HIV prevention

HealthEAM Jaishankar joins diplomatic corps in Delhi to participate in International Day of Yoga

HealthYoga Day aims for healthier planet: Om Birla leads celebrations at Parliament

HealthIDY2025: Yoga vital for mental health, cuts down stress, say Ministers